Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

NDCN researchers lead a global study based on analysing survey data

Close up of hands of two people working at desk with laptops and papers

Dr Arjune Sen heads up the Oxford Epilepsy Research Group. In partnership with local charity SUDEP Action, he will lead a project to investigate how COVID-19 has impacted on people with epilepsy, their carers and health care workers. In particular, they are interested in assessing escalation and mitigation of risk.

The team will be addressing this question using data from across the globe. They will employ surveys using the online JISC platform - pilot surveys are currently being reviewed and translated into multiple languages. The data will be entered anonymously and analysed in aggregated. It is hoped that as many as 500 participants will be engaged.

The aim is to use the findings to make specific recommendations on how to manage risk in people with epilepsy during the coronavirus pandemic and beyond. The team will highlight challenges and opportunities in a global context which can inform and improve patient care and help save lives.

Initially this work will be funded by the Oxfordshire Biomedical Research Centre and SUDEP Action. Collaborators include University College London and Professor Charles Newton from the Department of Psychiatry at the University of Oxford.

 

 

Similar stories

Study reveals association between diagnosis of a neuropsychiatric condition and severe outcome from COVID-19 infection, and other severe acute respiratory infections

New research from the University of Oxford has shown an increased risk of severe illness and death from both COVID-19 and other severe respiratory infections, such as influenza and pneumonia, among people with a pre-existing mental health condition.

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.

Visit from the Sir Jules Thorn Charitable Trust

Earlier this month, we were delighted to welcome the Director of the Sir Jules Thorn Charitable Trust, Richard Benson, and its Chair of Trustees, Liz Charal.

Oxford receives £122m funding for healthcare research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. Our department will play a major role.